Novel Mycobacterium tuberculosis thioredoxin reductase inhibitors with antimycobacterial activity in infected macrophages that overcomes problems of current anti-tuberculotics.
[更多]
PPI-benzimidazole analogues for the treatment of multidrug-resistant tuberculosis.
[更多]
PPI-benzimidazole analogues for the treatment of multidrug-resistant tuberculosis.
[更多]